A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

BACKGROUND: Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. However, there are few data on the safety and efficacy of paclitaxel plus ramucirumab in patients with AGC wit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Matsumoto, Hiroshi, Kawazoe, Akihito, Shimada, Kaoru, Fukuoka, Shota, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Ohtsu, Atsushi, Yoshino, Takayuki, Doi, Toshihiko, Shitara, Kohei
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793350/
https://ncbi.nlm.nih.gov/pubmed/29385993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4057-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares